What may be the biggest racket of the century won't hit prime time news anytime soon. Yet, internal documents and correspondence reveal this government agency, instead of working to protect your health, may be in the business of actually creating public health threats so it can profit from them.
Conflicts of Interest: Pfizer's Secret Collusion With the NIH
STORY AT-A-GLANCE
Under the 1984 Bayh-Dole Act, government scientists can collect royalties from drug companies for discoveries they make while working on the public’s dime
Taxpayers fund government research, while Big Pharma, the National Institutes of Health and NIH scientists keep all the profits
As a patent holder who profits from royalties, the NIH has a significant stake in regulations that impact patents and vaccine mandates, and may use its influence to benefit itself rather than the public
The NIH distributes $32 billion of taxpayer funds as research grants each year. As the largest federal grant-maker, the NIH has a monopoly on what research gets done and what doesn’t
Scientists vying for grants also recognize that in order to get funding, they have to play by the rules, and that means doing work that supports establishment narratives on public health policy
____________________________________________________________________________________________
In late February 2023, Moderna agreed to pay $400 million to the National Institute of Allergy and Infectious Diseases (NIAID) for the patent it holds on Moderna's mRNA shot.1
The patent process is a part of the COVID mRNA shots that the media haven't really addressed and people in general don't know anything about — probably because it's a total racket. Based on internal documents and correspondence, it appears the NIAID funded the creation of SARS-CoV-2. At the same time, it patented and receives royalty payments for the "vaccine" against said virus.
The National Institutes of Health (NIH) is supposed to be the primary government agency responsible for public health research, but by the looks of it, it appears instead to be in the business of creating public health threats in order to profit from them.
And the agency itself isn't the only one raking in profits. Many patents are held by individuals working at the NIH/NIAID. So, taxpayers fund research that may or may not work out, while Big Pharma, the NIH and individuals at the NIH profit from products that end up on the market. This is a clear conflict of interest that can hurt public health in any number of ways.
For starters, it incentivizes the NIH to support and promote potentially dangerous drugs, as we've clearly seen during the COVID pandemic. The NIH also has a significant stake in regulations that impact patents and vaccine mandates, and may use its influence to benefit itself rather than the public.
Conflicts of Interest Influence Public Health Policy
In the Full Measure video above, investigative journalist Sharyl Attkisson reports the findings of watchdog group Open The Books, which recently took a deep dive into "the issue of government scientists collecting royalty payments from pharmaceutical companies for discoveries made while working on your dime."
The NIH distributes $32 billion of taxpayer funds as research grants each year. As the largest federal grant-maker, the NIH has a monopoly on what research gets done and what doesn't.